EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of 68Ga-labeled macrocyclic peptide for targeting stimulator of interferon genes

Jingru Zhang, Lingxin Meng, Huifeng Li, Dongsheng Xia, Xiaobo Wang, Rongqiang Zhuang, Huanhuan Liu, Yesen Li, Xianzhong Zhang, Jianyang Fang, Zhide Guo

Acta Pharmaceutica Sinica B · 2026-11 · 16 (11) · 7508-7518

DOI: 10.1016/j.apsb.2026.03.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-11. Verfasst von Jingru Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, National Innovation Platform for Industry-Education Integr…. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Xiamen University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

DoxorubicinGallium-68ImmunotherapyMacrocyclic peptidePET imagingRadiotracerSTINGTumor microenvironment

Autor:innen und Institutionen

  • State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, National Innovation Platform for Industry-Education Integration in Vaccine Research, Center for Molecular Imaging and Translatio…
  • Department of Nuclear Medicine and State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
  • Department of Nuclear Medicine, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, China.
  • Theranostics and Translational Research Center, National Infrastructures for Translational Medicine, Institute of Clinical Medicine & Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academ…
  • School of Medical Imaging, Fujian Medical University, Fuzhou 350122, China.
  • Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou 363000, China.

Förderung

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Xiamen University

Zitieren

APA

Zhang, J., Meng, L., Li, H., Xia, D., Wang, X., Zhuang, R., Liu, H., Li, Y., Zhang, X., Fang, J., & Guo, Z. (2026). Development of 68Ga-labeled macrocyclic peptide for targeting stimulator of interferon genes. Acta Pharmaceutica Sinica B, 16(11), 7508-7518. https://doi.org/10.1016/j.apsb.2026.03.010

Vancouver

Zhang J, Meng L, Li H, Xia D, Wang X, Zhuang R, et al. Development of 68Ga-labeled macrocyclic peptide for targeting stimulator of interferon genes. Acta Pharmaceutica Sinica B. 2026;16(11):7508-7518. doi:10.1016/j.apsb.2026.03.010

BibTeX
@article{Zhang2026,
  author = {Zhang, Jingru and Meng, Lingxin and Li, Huifeng and Xia, Dongsheng and Wang, Xiaobo and Zhuang, Rongqiang and Liu, Huanhuan and Li, Yesen and Zhang, Xianzhong and Fang, Jianyang and Guo, Zhide},
  title = {Development of 68Ga-labeled macrocyclic peptide for targeting stimulator of interferon genes},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {7508--7518},
  doi = {10.1016/j.apsb.2026.03.010}
}
Kostenlos starten →